Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 mai 2026 16h05 HE | Source: Trevi Therapeutics, Inc.

Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates

Trevi Therapeutics to host conference call and webcast today, May 5, on 1Q 2026 financial results and business updates
28 avr. 2026 16h05 HE | Source: Trevi Therapeutics, Inc.

Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026

NEW HAVEN, Conn., April 28, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral...
17 mars 2026 16h05 HE | Source: Trevi Therapeutics, Inc.

Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates

Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with idiopathic pulmonary fibrosis-related chronic cough On...